SLFN11 and cancer: Epigenetic modifications, which are frequent in tumorigenesis and chemoresistance, are responsible for the lack of SLFN11 expression in many cancer cells, resulting in chemoresistance to widely used clinical agents that target DNA replication [11,15,121,124,125,126].